BAM
LFCR icon

Barrett Asset Management’s Lifecore Biomedical LFCR Stock Holding History

Barrett Asset Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,000
Closed -$11K – 359
2014
Q1 		$11K Buy
+1,000
New +$11K ﹤0.01% 308

Other funds holding LFCR

GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $930M AUM 16.14% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
KG
Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barrett Asset Management's LFCR Position: Q2 2014 in Review

Barrett Asset Management sold out of Lifecore Biomedical (LFCR) in Q2 2014, closing a stake of 1,000 shares — an estimated $11K sold.

Barrett Asset Management first reported a position in LFCR in Q1 2014 and held it in 1 quarter. The position peaked at $11K in Q1 2014. 101 funds tracked by Wall St. Rank hold LFCR as of Q2 2014.

  • Barrett Asset Management reported no remaining Lifecore Biomedical position as of Q2 2014 after selling out during the quarter.
  • Barrett Asset Management sold 1,000 Lifecore Biomedical shares in Q2 2014, an estimated $11K.
  • Barrett Asset Management first reported a position in Lifecore Biomedical in Q1 2014 and held it in 1 quarter.
  • Barrett Asset Management's Lifecore Biomedical position peaked at $11K in Q1 2014.
  • 101 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2014.

Based on Barrett Asset Management's 13F filing for Q2 2014, filed 4 Aug 2014.